|
QBI Number
|
Reagent Name
|
Reagent Description |
| 305341b |
SIVmac251 Stock day 7 |
SIVmac251 primary stock (4-19-91) derived from RhPBMC, harvested 7 days post-infection |
| 305342b |
SIVmac251 Stock day 8 |
SIVmac251 primary stock (4-19-91) derived from RhPBMC, harvested 8 days post-infection |
| 306080 |
SHIV CHAVI C5 / 293T Supernatant |
SIV contains HIV-1 C5 Env, derived from 293T cells |
| 306083 |
SIVmac239 challenge stock |
SIVmac239 derived from RhPBMC, stock titer generated in CEMx174 cells |
| 306089 |
SHIV.C.CH848.375H.dCT challenge stock |
SIV contains HIV-1 CH848 (T/F), Env with mutation at 375 (S to H), derived from RhCD4+ T cells |
| 306090 |
SHIV.C.CH505.375H.dCT challenge stock |
SIV contains HIV-1 CH505 (T/F), Env with mutation at 375 (S to H), derived from RhCD4+ T cells |
| 306091 |
SHIV.C.1086.375W.dCT challenge stock |
SIV contains HIV-1 1086 (T/F), Env with mutation at 375 (S to W), derived from RhCD4+ T cells |
| 306099 |
SHIV.A.BG505.332N.375Y.dCT challenge stock |
SIV contains HIV-1 BG505 (T/F), Env with mutations at 332N and 376 (S to W), derived from RhCD4+ T cells |
| 306100 |
SHIV.C.1012.375Y.dCT challenge stock |
SIV contains HIV-1 CH1012 (T/F), Env from subject CH1012, derived from RhCD4+ T cells |
| 306101 |
SHIV.C.Ce1176.375HFW challenge stock |
SIV contains HIV-1 Ce1176 (subtype C, T/F), Env with mutation at 375 HFW mixture alleles, derived from RhCD4+ T cells |
| 306102 |
SHIV.B.B41.375H.dCT challenge stock |
SIV contains HIV-1 B41 (subtype B,T/F), Env from subject 9032-08.A1.4685, derived from RhCD4+ T cells |
| 306109 |
SHIV.AG.T250-4.375HWY.dCT challenge stock |
SIV contains HIV-1 T250-4 (subtype AG), Env with mutation at 375 HWY mixture alleles, derived from RhCD4+ T cells |